Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
Bain Capital Life Sciences is an investment firm that backs pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies worldwide. It pursues opportunities across the value chain—including inflection capital, growth capital, fallen angels, and private equity collaborations—to advance treatments for patients with unmet medical needs.
3 investors
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease. The company focuses on stroke and cardiovascular applications.
3 investors
The company builds "Biological Adapters" that integrate living neurons with AI foundation models to improve performance and reduce training cost, and it operates an algorithm discovery platform based on principles from biological neural systems. Its technology (TBC) targets applications such as computer vision, generative video, world models, robotics, and time-series prediction.
3 investors
Becoming.ai develops robotic closed-loop hardware that sustains mammalian development externally—regulating nutrients, waste, and gas exchange—paired with AI models that learn to predict how development unfolds and responds to intervention. The platform combines biology, robotics, and machine learning to make developmental processes testable and predictable, targeting research into developmental disease.
3 investors
Clinical-stage biopharmaceutical company developing controllable cell therapies, including next-generation CAR-T, TCR and allogeneic T cell products such as rivo-cel and the GoCAR-T candidate BPX-601.
3 investors
The Better Meat Co. develops fermentation-based technology to produce alternative protein ingredients, aiming to build a more sustainable food system. It applies expertise from the food and agriculture industry to create novel proteins.
3 investors
Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains. The company serves pharmaceutical researchers developing treatments for brain diseases.
3 investors
Beyond Barriers Therapeutics develops BBT-101, an intranasal therapy for mild and moderate concussions intended for rapid deployment at the point of injury. The company focuses on providing the first FDA-approved frontline treatment for brain injuries across military, athletic, and civilian populations.
3 investors
BigOmics offers Omics Playground, an interactive bioinformatics platform for analyzing transcriptomics, proteomics, metabolomics, lipidomics, and methylation data. The self-service software is designed for both biologists and bioinformaticians to run reproducible omics analyses.
3 investors
Biodock provides an AI image analysis platform designed for researchers and scientists to train, run, and interpret deep learning models on biological images without requiring coding expertise. The platform enables rapid model creation, distributed execution at scale, and detailed quantitative analysis for research organizations in biotech and life sciences.
3 investors
Bio Eutectics develops Natural Deep Eutectic Systems, bio-sourced solvents made from natural acids, amino acids, alcohols, and sugars to replace petrochemical solvents in industrial processes. It customizes these green chemistry solutions for manufacturers across industries seeking lower-toxicity, lower-volatility alternatives.
3 investors
Biofidelity develops genomic biomarker testing technologies—its Aspyre and Enspyre products—for cancer detection, treatment selection, and minimal residual disease monitoring. The company serves oncology providers and patients with precision genomic diagnostics across the cancer patient journey.
3 investors
Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
3 investors
BioGeneration Ventures is a venture capital investor focused on early-stage biotech and life sciences companies. It works with a network of universities, startups, and large pharmaceutical companies to build and accelerate product development.
3 investors
Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.
3 investors
BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.
3 investors
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
3 investors
BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.
3 investors
Biolojic uses machine learning to design programmable human antibodies, including epitope-specific binders and multi-specific "multibodies," that act as functional switches targeting validated biological pathways. Its drug pipeline focuses on treatments for autoimmune diseases and immuno-oncology.
3 investors
Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
3 investors
BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.
3 investors
Bioqore builds Voyager, an AI-powered closed-loop bioprocess intelligence platform that combines predictive modeling with micro-scale laboratory experiments to recommend and validate optimal process conditions for producing preclinical- and clinic-ready therapeutic candidates. It serves biotech and pharma teams working on bioprocess development, scale-up, and biomanufacturing.
3 investors
Biorez develops the BioBrace, a bioinductive implant combining Type I collagen with PLLA microfilaments to reinforce and support soft tissue and tendon healing, including rotator cuff and foot & ankle repairs. The implant is used in open and arthroscopic surgical procedures for soft tissue augmentation.
3 investors
Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
3 investors